Saturday, November 27, 2021
Home Tags Zydus Cadila

Tag: Zydus Cadila

Zydus seeks DCGI nod for chronic Kidney disease drug

Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has submitted the New Drug Application (NDA) to the Drug Controller General...

Zydus Cadila gets USFDA nod to market generic Cancer drug in...

Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Decitabine injection, used to treat certain types of...

USFDA gives nod to Zydus Pharma for Eluxadoline Tablets

Zydus Cadila said today that its US subsidiary, Zydus Pharmaceuticals (USA) Inc., has obtained provisional permission from the US Food and Drug Administration (USFDA) to comercialise Eluxadoline Tablets in 75 mg and 100 mg dosages (US RLD: VIBERZI Tablets). Irritable bowel syndrome with diarrhoea or IBS-D, is treated with Eluxadoline Tablets in adults.

USFDA gives final nod to Zydus Cadila for Glycopyrrolate Injection

Ahmedabad, India: Global pharmaceutical company Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market its glycopyrrolate injection,...

Zydus Cadila to reduce its Vaccine price

New Delhi: Zydus Cadila has agreed to bring down the price of its C-19 vaccine to Rs 265 a dose following persistent negotiations...

USFDA gives tentative nod to Zydus Cadila for Adapalene and Benzoyl...

Zydus Cadila has received tentative approval from the US Food and Drugs Administration (USFDA) to market Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%....

Zydus vaccine likely to cost Rs 300 a dose

Zydus Cadila's C-19 vaccine may cost around Rs 300 per dose, people in the know told ET. As government inches closer to deciding the...

Zydus Cadila proposes Rs 1900 for three dose C-19 vaccine

With talks underway between the central government and Zydus Cadila over the pricing of the C-19 vaccine ZyCov-D, the pharma company is...

Govt to introduce needle free Vaccine shortly

The government yesterday said Zydus Cadila’s indigenously-developed needle-free C-19 vaccine ZyCoV-D will be introduced in the nationwide anti C-19 virus vaccination drive...

Zydus Cadila gets USFDA nod for drug to treat Psoriasis

NEW DELHI: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Apremilast tablets, used to...

Vaccination for 12+ kids in India likely to start next month

All Indian children aged 12 or older will become eligible for C-19 vaccinations from next month, when drug maker Cadila Healthcare launches...

Zydus Cadila gets USFDA nod for Antidepressant drug

Zydus Cadila has received final approval from the USFDA to market Vortioxetine Tablets in the strengths of 5 mg, 10 mg, 20...

Zydus Cadila gets tentative nod from USFDA for Brexpiprazole tablets

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brexpiprazole tablets in the strength of...

India: First commercial batch of COVAXIN released

Gujarat : Releasing the first commercial batch of COVAXIN manufactured in Ankleshwar, a manufacturing capacity of more than 1 crore C-19 doses per month...

Zydus Cadila gets USFDA nod for Tofacitinib ER Tablets

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market tofacitinib extended release tablets, 11 mg...

Zydus Cadila gets USFDA nod for Mesalamine ER capsules

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market mesalamine extended-release capsules in the strength...

Zydus Cadila gets final nod from USFDA for Fulvestrant injection

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Fulvestrant injection, 250 mg/5 mL...

CDSCO grants permission to these 3 private C-19 Vaccines

The Central Drugs Standard Control Organisation (CDSCO) has granted manufacturing permission to private manufacturers for three corona virus vaccines for restricted use...

Zydus Cadila gets USFDA nod for drug to treat HIV infection

Zydus Cadila has received final approval from US Food and Drug Administration (USFDA) to market emtricitabine and tenofovir disoproxil fumarate tablets, 100...

Zydus Cadila gets tentative nod from USFDA for Pemetrexed for Injection

Zydus Cadila has received tentative approval from the USFDA to market Pemetrexed for Injection in the strengths of 100mg/vial, 500 mg/vial, and...

Zydus Cadila gets tentative nod from USFDA for Fingolimod Capsules

Zydus Cadila has received tentative approval from the United States US (USFDA) to market Fingolimod capsules in the strength of 0.25 mg...

Zydus Cadila gets tentative USFDA nod for Epilepsy drug

Zydus Cadila has received tentative approval from the USFDA to market Brivaracetam Tablets, in the strengths of 10 mg, 25 mg, 50...

Zydus Cadila gets nod for Clinical Trials of Antibodies cocktail

New Delhi: The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of C-19 has been given...

Zydus Cadila gets tentative USFDA nod for Osimertinib Tablets

Zydus Cadila has received tentative approval from the USFDA to market Osimertinib Tablets in the strengths of 40 mg and 80 mg...

Latest posts

High Court restrains publishing Ads in a dispute on Chyawanprash

The Calcutta High Court has issued an interim injunction restraining Shree Baidyanath Ayurved Bhawan Pvt Ltd from issuing certain print and video...

Authors

58 POSTS0 COMMENTS
30 POSTS0 COMMENTS
20 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS